InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: BCS Paladin post# 204264

Wednesday, 01/28/2015 9:20:09 PM

Wednesday, January 28, 2015 9:20:09 PM

Post# of 345956
My puzzle pieces tell me Art was asked to leave BOD of Roche once it was confirmed Calico was about to become a major player in the future of Big Pharma and no Roche agendas could take place with Art listening in. He is about to be nominated back again as BOD for Apple is a good friend to have.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News